Clinical Trials Browser

Phase 3 × INDUSTRY × apixaban × Clear all

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02369653 2022-03-08

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Phase 3 Completed

512 enrolled 26 charts

LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma